Exploiting the proteomics revolution in biotechnology: from disease and antibody targets to optimizing bioprocess development.
about
Posttranslational Modifications and the Immunogenicity of BiotherapeuticsThe future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.Progress in the development of immunoanalytical methods incorporating recombinant antibodies to small molecular weight biotoxins.CHOgenome.org 2.0: Genome resources and website updates.
P2860
Exploiting the proteomics revolution in biotechnology: from disease and antibody targets to optimizing bioprocess development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Exploiting the proteomics revo ...... mizing bioprocess development.
@en
type
label
Exploiting the proteomics revo ...... mizing bioprocess development.
@en
prefLabel
Exploiting the proteomics revo ...... mizing bioprocess development.
@en
P2093
P1476
Exploiting the proteomics revo ...... mizing bioprocess development.
@en
P2093
Amit Kumar
Deniz Baycin Hizal
Joseph Shiloach
Kelley M Heffner
Michael A Bowen
Michael J Betenbaugh
P356
10.1016/J.COPBIO.2014.06.006
P577
2014-07-03T00:00:00Z